abrocitinib;
itching;
JAK inhibitor;
prurigo nodularis;
D O I:
10.1002/ccr3.8606
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Prurigo nodularis is frequently difficult to manage with conventional therapy. Given the pathogenesis and refractory nature, we demonstrate a case in which inhibition of JAK-STAT signaling may significantly improve prurigo nodularis. Based on the results, we would like to draw a conclusion that abrocitinib as an inhibitor of Jak is a promising choice for the treatment of prurigo nodularis.
机构:
Hlth Dept Rio Grande do Sul State SES RS, Sanit Dermatol Outpatient Clin, Porto Alegre, BrazilHlth Dept Rio Grande do Sul State SES RS, Sanit Dermatol Outpatient Clin, Porto Alegre, Brazil
Alves, Juliana P.
Heck, Renata
论文数: 0引用数: 0
h-index: 0
机构:
Hlth Dept Rio Grande do Sul State SES RS, Sanit Dermatol Outpatient Clin, Porto Alegre, BrazilHlth Dept Rio Grande do Sul State SES RS, Sanit Dermatol Outpatient Clin, Porto Alegre, Brazil
机构:
Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover, 30625 HannoverKlinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover, 30625 Hannover
Raap U.
Günther C.
论文数: 0引用数: 0
h-index: 0
机构:
Klinik und Poliklinik für Dermatologie, Universitätsklinikum Carl Gustav Carus Dresden, DresdenKlinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover, 30625 Hannover